180 related articles for article (PubMed ID: 8818852)
1. Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections.
Laurent K
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():115-24. PubMed ID: 8818852
[TBL] [Abstract][Full Text] [Related]
2. An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections.
Müller O
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():83-92. PubMed ID: 8818849
[TBL] [Abstract][Full Text] [Related]
3. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
Gris P
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
[TBL] [Abstract][Full Text] [Related]
4. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
Bradbury F
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087
[TBL] [Abstract][Full Text] [Related]
5. A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections.
Zachariah J
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():103-13. PubMed ID: 8818851
[TBL] [Abstract][Full Text] [Related]
6. Open clinical trial of roxithromycin in patients of Plateau Hospitals, Jos in upper and lower respiratory tract infections.
Okeke EN; Juryit Z; Ikeh EI
West Afr J Med; 1995; 14(4):238-41. PubMed ID: 8634230
[TBL] [Abstract][Full Text] [Related]
7. An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients.
Isah AO; Ohaju-Obodo J
West Afr J Med; 1996; 15(2):111-6. PubMed ID: 8855675
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of and tolerance to azithromycin versus roxithromycin in the treatment of patients with acute infections of the upper respiratory tract].
Bosatra A; Tattoni P; Podda M; Pirodda E; Buccolieri M; Amorosa L
Clin Ter; 1994 Jan; 144(1):27-30. PubMed ID: 8168348
[TBL] [Abstract][Full Text] [Related]
9. An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.
O'Doherty B
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():71-81. PubMed ID: 8818848
[TBL] [Abstract][Full Text] [Related]
10. Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia.
Salvarezza CR; Mingrone H; Fachinelli H; Kijanczuk S
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():75-80. PubMed ID: 9579717
[TBL] [Abstract][Full Text] [Related]
11. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
Soepandi P; Mangunnegoro H; Yunus F; Gunawan J
Respirology; 1998 Jun; 3(2):113-7. PubMed ID: 9692520
[TBL] [Abstract][Full Text] [Related]
12. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of azithromycin in lower respiratory tract infections.
Morandini G; Perduca M; Zannini G; Foschino MP; Miragliotta G; Carnimeo NS
J Chemother; 1993 Feb; 5(1):32-6. PubMed ID: 8384658
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin. A review of its use in paediatric infectious diseases.
Langtry HD; Balfour JA
Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
[TBL] [Abstract][Full Text] [Related]
16. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice.
Tilyard MW; Dovey SM
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):97S-101S. PubMed ID: 1617932
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
Poirier R
J Antimicrob Chemother; 1991 Feb; 27 Suppl A():109-16. PubMed ID: 1827096
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections.
Tatsis G; Tsoukalas G; Boulbasakos G; Platsouka E; Anagnostopoulou M; Pirounaki M; Paniara O; Sioula E; Raptis J; Saroglou G
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():69-73. PubMed ID: 9579716
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
20. Open clinical trial of roxithromycin amongst patients of Jos University Teaching Hospital with lower and upper respiratory tract infections.
Idoko JA; Anteyi EA; Ighogboja IS; Ikeh EI
West Afr J Med; 1995; 14(3):127-33. PubMed ID: 8519697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
